Chinook Therapeutics (KDNY) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 24 252 sessions, August 18, 2022 to August 18, 2023
- Largest daily move
- +58.3% close of June 12, 2023
- 1-year change
- +85.7% closing prices, August 18, 2022 to August 18, 2023
- 1-month change
- +2.6% closing prices, July 18, 2023 to August 18, 2023
Company Description
Chinook Therapeutics (NASDAQ: KDNY) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $2.7B.
KDNY has gained 85.7% over the past year. The last closing price was $40.39.
This page collects what Stock Titan holds for KDNY, including price data and latest news.
Stock Performance
Chinook Therapeutics (KDNY) closed at $40.39 on August 18, 2023. Over the past 12 months, the price has gained 85.7%.
KDNY Metrics & Rankings
Price returns through August 18, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Chinook Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, conferences, partnership, earnings, management. View all KDNY news →
SEC Filings
KDNY Company Profile & Sector Positioning
Chinook Therapeutics (KDNY) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing KDNY often look at related companies in the same sector, including Ultragenyx Pharmaceutical Inc. (RARE), Immunovant, Inc. (IMVT), Viking Therapeutics, Inc (VKTX), Amicus Therapeutics, Inc (FOLD), and Scholar Rock Holding Corporation (SRRK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KDNY's relative position within its industry.